Abstract

PurposeTo evaluate the reliability of ultrasound hepatorenal index (US-HRI) and magnetic resonance imaging proton density fat fraction (MRI-PDFF) techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy proton density fat fraction (MRS-PDFF) as the reference standard.Materials and methodsFifty-two adult volunteers (30 men, 22 women; age, 31.5 ± 6.5 years) who had no history of kidney disease or viral/alcoholic hepatitis were recruited to undergo abdominal US, MRI, and MRS examinations. US-HRI was calculated from the average of three pairs of regions of interest (ROIs) measurements placed in the liver parenchyma and right renal cortex. On MRI, the six-point Dixon technique was employed for calculating proton density fat fraction (MRI-PDFF). An MRS sequence with a typical voxel size of 27 ml was chosen to estimate MRS-PDFF as the gold standard. The data were evaluated using Pearson’s correlation coefficient and receiver operating characteristic (ROC) curves.ResultsThe Pearson correlation coefficients of US-HRI and MRI-PDFF with MRS-PDFF were 0.38 (p = 0.005) and 0.95 (p<0.001), respectively. If MRS-PDFF ≥5.56% was defined as the gold standard of fatty liver disease, the areas under the curve (AUCs), cut-off values, sensitivities and specificities of US-HRI and MRI-PDFF were 0.74, 1.54, 50%, 91.7% and 0.99, 2.75%, 100%, 88.9%, respectively. The intraclass correlation coefficients (ICCs) of US-HRI and MRI-PDFF were 0.70 and 0.85.ConclusionMRI-PDFF was more reliable than US-HRI in diagnosing hepatic steatosis.

Highlights

  • Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder

  • NAFLD is considered an important cause of fibrosis progression, nonalcoholic steatohepatitis (NASH), and hepatocellular carcinoma (HCC) [2]

  • The purpose of this study was to evaluate the reliabilitiy of fat quantification by US (US-HRI) and MRI-PDFF techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy (MRS)-PDFF as the reference standard

Read more

Summary

Introduction

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder. A meta-analysis reported a prevalence of 24% in the worldwide population [1]. NAFLD is considered an important cause of fibrosis progression, nonalcoholic steatohepatitis (NASH), and hepatocellular carcinoma (HCC) [2]. NAFLD has shown a strong association with coronary artery disease, osteoporosis, metabolic syndrome [3], and rheumatoid arthritis [4]. The prevalence of NAFLD varies with age, gender, and weight status [5]. Detection and quantification of hepatic steatosis play an important role in treatment because NAFLD can be treated by control of diabetes, weight loss or lifestyle modification [6]

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.